Ameritas Investment Partners, Inc.

Position in ROIV — Roivant Sciences Ltd.

CIK 1055980 LINCOLN, NE

Position in ROIV

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,300,872

+$550,876 QoQ

Shares Held

83,064

+3.0% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Ameritas Investment Partners, Inc. holds $51,229,251 across 215 Biotechnology names. ROIV ranks #5 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	12,563	$5,609,881
2	REGN	Regeneron Pharmaceuticals, Inc.	4,656	$3,597,411
3	EXEL	Exelixis, Inc.	70,554	$3,026,060
4	ARWR	Arrowhead Pharmaceuticals, Inc.	36,974	$2,318,269
5	ROIV	Roivant Sciences Ltd. This page	83,064	$2,300,872
6	CYTK	Cytokinetics Inc	32,284	$2,127,838
7	JAZZ	Jazz Pharmaceuticals plc	11,194	$2,116,225
8	BMRN	Biomarin Pharmaceutical Inc	35,392	$1,999,294

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,300,872	83,064	+3.0%	Shares	Other	2026-05-13
2025-12-31	$1,749,996	80,645	0.0%	Shares	Other	2026-02-11
2025-09-30	$1,220,158	80,645	-1.3%	Shares	Other	2025-11-10
2025-06-30	$921,209	81,740	-1.3%	Shares	Other	2025-08-12
2025-03-31	$835,784	82,833	-3.7%	Shares	Other	2025-05-12
2024-12-31	$1,017,675	86,025	-3.9%	Shares	Other	2025-02-13
2024-09-30	$1,033,003	89,515	+24.3%	Shares	Other	2024-11-13
2024-06-30	$760,923	71,989	-3.2%	Shares	Other	2024-08-13
2024-03-31	$784,176	74,400	—	Shares	Other	2024-05-13
No filing history on record for this holder in this stock.